Home Page

Canntab Enters into Supply Agreement with FSD Pharma and World Class Extractions on Organic Hemp Deal

Read more ››

By: Nasdaq / GlobenewsWire - 12 Feb 2019

Related companies:  Canntab Therapeutics Limited

Conatus Announces Completion of Enrollment in ENCORE-LF Phase 2b Clinical Trial of Emricasan in Patients with Decompensated NASH Cirrhosis

Read more ››

By: Nasdaq / GlobenewsWire - 12 Feb 2019

Related companies:  Conatus Pharmaceuticals Inc.

ADMA Biologics Enters Into $72.5 Million Loan Facility with Perceptive Advisors

Read more ››

By: Nasdaq / GlobenewsWire - 12 Feb 2019

Related companies:  ADMA Biologics, Inc.

BioSig Technologies Inc. Issues 2019 Shareholder Letter

Read more ››

By: Nasdaq / GlobenewsWire - 12 Feb 2019

Related companies:  BioSig Technologies, Inc.

Progressive Care Inc. Announces CEO, Shital Mars as Keynote Speaker at Cold Chain Global Forum in Toronto, Canada

Read more ››

By: Nasdaq / GlobenewsWire - 12 Feb 2019

IRIDEX Announces Resolution of its Dispute with Quantel Medical

Read more ››

By: Nasdaq / GlobenewsWire - 12 Feb 2019

Related companies:  IRIDEX Corporation

WW Schedules Fourth Quarter and Full Year 2018 Earnings Conference Call

Read more ››

By: Nasdaq / GlobenewsWire - 12 Feb 2019

Medexus Lists October 2018 Unsecured Convertible Debentures on the TSX Venture Exchange

Read more ››

By: Nasdaq / GlobenewsWire - 12 Feb 2019

Related companies:  Medexus Pharmaceuticals, Inc.

Coloplast continues to expand its SenSura® Mio ostomy range with the new, innovative, first-of-its-kind SenSura® Mio Convex Flip ostomy product.

Read more ››

By: Nasdaq / GlobenewsWire - 12 Feb 2019

Related companies:  Coloplast A/S

Ultragenyx to Host Conference Call for Fourth Quarter and Full-Year 2018 Financial Results and Corporate Update

Read more ››

By: Nasdaq / GlobenewsWire - 12 Feb 2019

Related companies:  Ultragenyx Pharmaceutical, Inc.

Genocea Announces Private Placement Financing of Up to $39 Million

Read more ››

By: Nasdaq / GlobenewsWire - 12 Feb 2019

Related companies:  Genocea Biosciences, Inc.

Vericel to Report Fourth-Quarter 2018 Financial Results on February 26, 2019

Read more ››

By: Nasdaq / GlobenewsWire - 12 Feb 2019

Related companies:  Vericel Corporation

Ritter Pharmaceuticals to Host Expert Call with Dr. William Chey on February 20, 2019

Read more ››

By: Nasdaq / GlobenewsWire - 12 Feb 2019

Related companies:  Ritter Pharmaceuticals, Inc.

Teladoc Health to Announce Fourth Quarter and Full-Year 2018 Financial Results

Read more ››

By: Nasdaq / GlobenewsWire - 12 Feb 2019

Related companies:  Teladoc, Inc.

SELLAS Life Sciences Provides Galinpepimut-S and Nelipepimut-S Program Update

Read more ››

By: Nasdaq / GlobenewsWire - 12 Feb 2019

Veritas Pharma Enters into agreement to acquire Commercial Hemp and Cannabis Processing Facility

Read more ››

By: Nasdaq / GlobenewsWire - 12 Feb 2019

Related companies:  Veritas Pharma Inc.

Fortress Biotech Completes Final Stage Closing of the Sale of its Remaining Shares of National Holdings Corporation

Read more ››

By: Nasdaq / GlobenewsWire - 12 Feb 2019

Related companies:  Fortress Diagnostics Ltd | Fortress Biotech, Inc.

Researchers at Queen’s University Belfast have Developed a Vaginal Ring Capable of Providing Sustained Delivery of OB-002 (5P12-RANTES) for HIV Prevention

Read more ››

By: Nasdaq / GlobenewsWire - 12 Feb 2019

Related companies:  Orion Canada Inc.

AXIM® Biotechnologies Announces Significant Initial Purchase Order for Nutraceutical Product With Leading Direct Selling Company

Read more ››

By: Nasdaq / GlobenewsWire - 12 Feb 2019

Related companies:  AXIM Biotechnologies, Inc.

Ventura Cannabis to Acquire Cannabis Dispensaries in Cathedral City, California, and Portland, Oregon With Combined Annual Revenues of $2,500,000

Read more ››

By: Nasdaq / GlobenewsWire - 12 Feb 2019

«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19 20  21  22  23  24  25 »